Fluka 150 Tablet
₹13.00
What It Is
-
An azole antifungal medication containing 150 mg of fluconazole. It works by inhibiting the fungal enzyme needed for cell membrane integrity, effectively stopping and killing fungi
-
Prescription-only, non-habit forming
Indications
Used to treat a variety of fungal infections such as:
-
Oral and esophageal thrush
-
Vaginal candidiasis (single-dose therapy)
-
Yeast infections affecting skin, nails, urinary tract
-
Systemic fungal infections (e.g., cryptococcal meningitis)
Dosage & Administration
-
Typically taken as a single 150 mg dose for vaginal thrush; other fungal infections require prolonged therapy from 50–800 mg daily depending on severity
-
Can be taken with or without food; swallow whole and maintain consistent timing .
-
Continue full course—even if symptoms improve—to prevent recurrence or resistance
Side Effects
Common (typically mild):
-
Nausea, vomiting, diarrhea, stomach upset, headache, dizziness, rash
Less common/serious: -
Elevated liver enzymes (requires monitoring with prolonged use), allergic reactions, QT prolongation, hair loss, seizures, facial swelling
Drug Interactions
Interacts with medications such as:
-
Anticoagulants (e.g., warfarin)
-
CYP3A4-metabolized drugs (e.g., statins, antiepileptics like carbamazepine, phenytoin)
-
Drugs that prolong QT interval
-
Use caution and inform your physician of all current medications
Feature | Details |
---|---|
Active Ingredient | Fluconazole 150 mg |
Drug Class | Azole antifungal |
Key Uses | Candidiasis (oral/intestinal/vaginal), skin/nail infections, systemic fungal infections |
Common Side Effects | GI upset, headache, dizziness, rash |
Major Risks | Liver/kidney issues, QT prolongation, seizures, allergic reactions |
Administration | Single dose for uncomplicated vaginal thrush; longer regimens for systemic use |
Important Precautions | Avoid in pregnancy/breastfeeding unless essential, monitor organ function, beware drug interactions, restrict driving/alcohol if symptomatic |
Reviews
There are no reviews yet.